Overview Hepatic hemangioma is a relatively common benign tumor of the liver, with cavernous hemangioma being the most common in clinical practice. The detection rate of cavernous hemangioma in the natural population is 0.35-7.3% at autopsy, accounting for 5-20% of the benign tumors of the liver, and the incidence rate of cavernous hemangioma in the population has been reported in the literature to be about 5-7%. In recent years, with the improvement of people’s awareness of health checkups and the advancement of various diagnostic imaging techniques, the detection rate of asymptomatic small hemangiomas has increased significantly. Most cases are clinically asymptomatic, with a long course, slow growth, mild symptoms, and good prognosis. At present, there is not much basic and clinical research on this disease, and there is a lack of mature and strict diagnostic and treatment standards, and there are many ambiguities and even mistakes in the definition of treatment plans and indications. Traditional surgical treatment coexists with radiofrequency ablation, embolization of hepatic artery, radiotherapy, intraoperative microwave curing, freezing and sclerosing agent injection, and other treatment methods, and the treatment plan has not yet formed a more unified clinical path for doctors and patients to choose. The treatment program has not yet formed a more unified clinical pathway for doctors and patients to choose.